Israel is a global hub for neuro-oncology, offering innovative treatments like Tumor Treating Fields (Optune), CAR-T cell therapy, and intraoperative MRI. Specialized centers utilize robotic-assisted surgery and DaRT therapy to target aggressive glioblastomas. These advancements provide high precision while preserving critical brain functions.
- Optune (TTFields): Wearable helmet uses electric fields to disrupt cancer cell division.
- CAR-T therapy: Genetic modification of immune cells to target specific brain tumor markers.
- Intraoperative MRI: Real-time imaging during surgery ensures maximum tumor removal with high precision.
- DaRT therapy: Radioactive seeds release alpha particles directly inside the tumor for localized destruction.
Bookimed Expert Insight: Israeli medical centers like Sheba and Sourasky operate at a massive scale, treating up to 2 million patients annually. This high volume allows surgeons like Dr. Zvi Cohen to maintain a brain tumor tissue bank. This resource is vital for developing personalized vaccine protocols and pharmacological therapies tailored to a patient's specific genetic profile. Choosing a facility with an integrated tissue bank often leads to more precise treatment options.
Patient Consensus: Patients note that Israel offers faster access to experimental immunotherapy combinations than the US. Many emphasize that while costs are high, the ability to access portable device refinements and compassionate-use CAR-T programs is a significant advantage.